60 related articles for article (PubMed ID: 1864315)
1. Hormone analytical and carrier protein alternations following administration of mifepristone (RU 486) for termination of early pregnancy.
Klinger G; Carol W; Börner A; Michels W; Romero KR
Exp Clin Endocrinol; 1991 Mar; 97(1):63-7. PubMed ID: 1864315
[TBL] [Abstract][Full Text] [Related]
2. Hormone pattern after misoprostol administration for a nonviable first-trimester gestation.
Barnhart KT; Bader T; Huang X; Frederick MM; Timbers KA; Zhang JJ
Fertil Steril; 2004 Apr; 81(4):1099-105. PubMed ID: 15066470
[TBL] [Abstract][Full Text] [Related]
3. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy.
Yuen BH; Livingston JE; Poland BJ; Wittmann BK; Sy L; Cannon W
Obstet Gynecol; 1981 Feb; 57(2):207-14. PubMed ID: 7465126
[TBL] [Abstract][Full Text] [Related]
5. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy.
Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):134-9. PubMed ID: 15683372
[TBL] [Abstract][Full Text] [Related]
7. [Inducing embryo expulsion in women with spontaneous fetal death in the first trimester. Use of mifepristone (RU-486) in a prospective, randomized, double blind study].
Lelaidier C; Baton Saint-mleux C; Fernandez H; Bourget P; Frydman R
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):505-8. PubMed ID: 12318240
[TBL] [Abstract][Full Text] [Related]
8. Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
Gerhard I; Runnebaum B
Biol Res Pregnancy Perinatol; 1984; 5(4):157-73. PubMed ID: 6084523
[TBL] [Abstract][Full Text] [Related]
9. An antiprogestin steroid and PGE2 for an early pregnancy termination.
Hingorani V; Malhotra U; Kumar S; Saraya L; Sunesh K; Buckshee K
Acta Obstet Gynecol Scand Suppl; 1989; 149():25-9. PubMed ID: 2482650
[TBL] [Abstract][Full Text] [Related]
10. The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy.
Sitruk-Ware R; Thalabard JC; De Plunkett TL; Lewin F; Epelboin S; Mowszowicz I; Yaneva H; Tournaire M; Chavinie J; Mauvais-Jarvis P
Contraception; 1990 Mar; 41(3):221-43. PubMed ID: 2323217
[TBL] [Abstract][Full Text] [Related]
11. [The evaluation of serum hormone levels (beta HCG, E2, P) and E2/P in diagnosis of early ectopic pregnancy].
Zhang D; Wang Y; Zhang H; Liu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):125-7. PubMed ID: 7656392
[TBL] [Abstract][Full Text] [Related]
12. Alterations in saliva steroid hormone levels after oral mifepristone administration in women with pregnancies of greater than 41 weeks' gestation.
Fassett MJ; Lachelin GC; McGarrigle HH; Wing DA
Reprod Sci; 2008 Apr; 15(4):394-9. PubMed ID: 18497346
[TBL] [Abstract][Full Text] [Related]
13. Serum beta-human chorionic gonadotropin, estradiol and progesterone as early predictors of pathologic pregnancy.
Buyalos RP; Glassman LM; Rifka SM; Falk RJ; Macarthy PO; Tyson VJ; DiMattina M
J Reprod Med; 1992 Mar; 37(3):261-6. PubMed ID: 1373448
[TBL] [Abstract][Full Text] [Related]
14. Abortion: epidemiology, safety, and technique.
Blumenthal PD
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):506-12. PubMed ID: 1504270
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
Aubeny E; Bureau A; Gabeaud P; Heard I; Eucher M; Husson T; Meng L; Riotte S
Fertil Contracept Sex; 1989 Apr; 17(4):307-14. PubMed ID: 12282175
[TBL] [Abstract][Full Text] [Related]
16. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
Lelaidier C; Baton-Saint-Mleux C; Fernandez H; Bourget P; Frydman R
Hum Reprod; 1993 Mar; 8(3):492-5. PubMed ID: 8473474
[TBL] [Abstract][Full Text] [Related]
18. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.
Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N
Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723
[TBL] [Abstract][Full Text] [Related]
19. Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy.
Thong KJ; Brooks AN; Baird DT
Br J Obstet Gynaecol; 1993 Sep; 100(9):880-2. PubMed ID: 8218022
[TBL] [Abstract][Full Text] [Related]
20. Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
Wang JD; Shi WL; Zhang GQ; Bai XM
Contraception; 1994 Mar; 49(3):245-53. PubMed ID: 8200218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
